Home › Kanser (lahat ng uri) › Illinois › Chicago
Pag-aaral pangklinika para sa Kanser (lahat ng uri) sa Chicago, IL
Isang pag-aaral para sa Kanser (lahat ng uri) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Nagre-recruitPhase 1
- University of Chicago Medical Center /ID# 278863, Chicago
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Nagre-recruitObservasyonal na pag-aaral
- Northwestern University, Chicago
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Nagre-recruitPhase 3
- Investigative Site, Chicago
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Nagre-recruitPhase 3
- University of Illinois Chicago, Chicago
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Nagre-recruitPhase 3
- Northwestern Memorial Hospital, Chicago
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Nagre-recruitPhase 3
- University of Chicago Medical Center /ID# 280149, Chicago
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Nagre-recruitPhase 2
- Cancer Treatment Centers of America-Chicago, Chicago
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Nagre-recruitPhase 2/3
- Northwestern Memorial Hospital, Chicago
- University Of Chicago Medical Center, Chicago
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Nagre-recruitPhase 2
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
Evaluating the Communication Between Patients and Providers in Cancer Clinics
Nagre-recruit
- Northwestern Memorial Hospital, Chicago
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Nagre-recruit
- Advocate Illinois Masonic Medical Center, Chicago
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
Nagre-recruitPhase 1
- Northwestern University ( Site 0101), Chicago
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Nagre-recruitPhase 1
- University of Chicago, Chicago
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
Nagre-recruitObservasyonal na pag-aaral
- Ann &Robert H Lurie Children's Hospital, Chicago
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Nagre-recruitObservasyonal na pag-aaral
- Northwestern University Feinberg School of Medicine, Chicago
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Nagre-recruitPhase 3
- Insight Research Institute, Chicago
Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
Nagre-recruitObservasyonal na pag-aaral
- Ann & Robert H Lurie Childrens Hospital, Chicago
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Nagre-recruitPhase 3
- Northwestern University, Chicago
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Lurie Children's Hospital-Chicago, Chicago
- Northwestern University, Chicago
- University of Illinois, Chicago
- at 1 pa
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Nagre-recruitPhase 3
- University of Chicago, Chicago
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
- Site 05, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Nagre-recruitPhase 1/2
- University of Chicago Medical Center, Chicago
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Tempus AI, Chicago
International Rare Brain Tumor Registry
Nagre-recruitObservasyonal na pag-aaral
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Nagre-recruitPhase 2
- Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Nagre-recruitPhase 3
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- at 1 pa
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Nagre-recruitPhase 2
- Lurie Children's Hospital, Chicago
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- The University of Chicago Medicine, Chicago
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Nagre-recruitPhase 2
- University of Chicago Medical Center /ID# 274742, Chicago
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
Nagre-recruit
- Northwestern University, Chicago
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
Nagre-recruit
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Molecular Genetics Studies of Cancer Patients and Their Relatives
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- John H Stroger Jr Hospital of Cook County, Chicago
- Rush University Medical Center, Chicago
Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Northwestern University, Chicago
Childhood Cancer Survivor Study
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Ana & Robert H. Lurie Children's Hospital of Chicago, Chicago
- University of Chicago, Chicago
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
Nagre-recruitPhase 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Nagre-recruitPhase 1
- Context Investigational Site, Chicago
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Nagre-recruitPhase 1/2
- Northwestern Memorial Hospital, Chicago
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
Nagre-recruitObservasyonal na pag-aaral
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life
Nagre-recruit
- Northwestern University, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Nagre-recruitPhase 1/2
- University of Chicago, Chicago
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Nagre-recruitPhase 1/2
- University of Chicago Medical Center, Chicago
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Nagre-recruitPhase 2
- University of Chicago, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Nagre-recruitPhase 1/2
- Northwestern Memorial Hospital, Chicago
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Nagre-recruit
- University of Chicago Medicine, Chicago
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Nagre-recruitPhase 1/2
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Chicago
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Nagre-recruitPhase 1
- Northwestern University, Chicago
- University of Illinois, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
Nagre-recruitPhase 1
- University of Chicago, Chicago
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- Advocate Illinois Masonic Medical Center, Chicago
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
Nagre-recruitObservasyonal na pag-aaral
- Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital), Chicago
Pag-aaral para sa Kanser (lahat ng uri) sa ibang lungsod
- Houston, TX121 pag-aaral
- New York City, NY109 pag-aaral
- Boston, MA85 pag-aaral
- Los Angeles, CA74 pag-aaral
- Nashville, TN65 pag-aaral
- Philadelphia, PA59 pag-aaral
- Washington, DC58 pag-aaral
- Durham, NC58 pag-aaral
- Atlanta, GA49 pag-aaral
- Seattle, WA49 pag-aaral
- Arlington, VA48 pag-aaral
- St. Louis, MO46 pag-aaral
Iba pang pag-aaral sa Chicago
- Non-Small Cell Lung Cancer61 pag-aaral
- Kanser sa Suso59 pag-aaral
- Metastatic Cancer45 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Kanser sa Baga41 pag-aaral
- Obesity41 pag-aaral
- Kanser sa Ovary36 pag-aaral
- Colorectal Cancer34 pag-aaral
- Stroke34 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Overweight29 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.